MCRB
#4307
Seres Therapeutics, Inc. - Common Stock
4.6 4 USD
+0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.75%
Monthly Change
-6.83%
6 month change
-47.63%
Year Change
-43.62%
Previous Close
4.5 6
Open
4.7 0
Low
4.6 4
High
4.8 5
Volume
26
Financials
- Market Capitalization 46.13 M
- Employee 66
- Founded 2010
- CEO Eric Shaff
- Website www.serestherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG0099X6859
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
23.25
Price to sales ratio
167.28
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4300 |  MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.21 USD | -1.63% | -1.63% | 0.00% | -15.97% | 45.71 M USD | ||
| 4303 |  CNTX Context Therapeutics Inc. - Common Stock | 0.50 USD | 0.00% | -5.66% | -18.03% | -43.82% | 45.94 M USD | ||
| 4312 |  GRCE Grace Therapeutics, Inc. - Common Stock | 2.18 USD | -0.91% | -1.36% | -5.22% | -45.23% | 45.86 M USD | ||
| 4319 |  EDSA Edesa Biotech, Inc. - Common Shares | 4.52 USD | +2.03% | -26.50% | -15.51% | +84.49% | 43.58 M USD |
Frequently asked questions about Seres Therapeutics, Inc.
What is the Seres Therapeutics, Inc. stock price today?
The current price of Seres Therapeutics, Inc. (MCRB) is 4.64. Over the past 24 hours, the stock has changed by +1.75%. Follow the MCRB chart for real-time price dynamics.
What is the stock ticker of Seres Therapeutics, Inc.?
Seres Therapeutics, Inc. trades under the ticker MCRB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Seres Therapeutics, Inc. stock going up?
MCRB has changed by +4.04% over the last week, -6.83% over the last month, and -43.62% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Seres Therapeutics, Inc.?
Seres Therapeutics, Inc. currently has a market capitalization of 46.13 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Seres Therapeutics, Inc. earnings last quarter?
Last quarter, Seres Therapeutics, Inc. reported earnings of 0.47 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Seres Therapeutics, Inc. revenue for the last quarter?
Seres Therapeutics, Inc. reported quarterly revenue of 736 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Seres Therapeutics, Inc. net income for the last quarter?
Seres Therapeutics, Inc. reported net income of 4.58 M for the last quarter. The previous quarter showed -19.91 M, which means net income changed by +123.01%.
How many employees does Seres Therapeutics, Inc. have?
As of the latest available data, Seres Therapeutics, Inc. has 66 employees. Workforce size can provide additional context about the company's scale and operations.
What is Seres Therapeutics, Inc. EBITDA?
Seres Therapeutics, Inc. EBITDA is -20.6 M, and its EBITDA margin is -2 799.32%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Seres Therapeutics, Inc. stock?
You can buy Seres Therapeutics, Inc. (MCRB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Seres Therapeutics, Inc. stock?
Investing in Seres Therapeutics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MCRB chart and related analysis on metatrader.com as part of your research.